Granisetron plus or minus alprazolam for emesis prevention in chemotherapy of lymphomas: A randomized multicenter trial

Leukemia and Lymphoma

Volumn 34, Issue 3-4, 1999, Pages 341-347

  Bauduer, Frédéric ^a   Coiffier, Bertrand ^b   Desablens, Bernard ^c  

^a CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

5 HT3 receptor antagonist; Antiemetics; Chemotherapy induced emesis; Granisetron; Lymphomas

Indexed keywords

ALPRAZOLAM; ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; GRANISETRON;

ADULT; AGED; ANXIETY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; VOMITING;

EID: 0032867779     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909050959     Document Type: Article

References (18)

1. Jones, A.L., Cunningham, D. (1993) The clinical care of patients receiving chemotherapy. In Emesis in anti-cancer therapy. Mechanisms and treatment, edited by P.L.R. Andrews and G.J. Sanger, pp. 229-246. London. Chapman and Hall Medical.
2. 3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy. A randomized study. Eur J Cancer, 29A, 1669-1672.
3. Altmaier, E.M., Ross, W.E., Moore, K. (1982) A pilot investigation of the psychologic function of patients with anticipatory vomiting. Cancer, 49, 201-204.
4. Cella, D.F., Pratt, A., Holland, J.C. (1986) Persistent anticipatory nausea, vomiting and anxiety in cured Hodgkin's disease patients after completion of chemotherapy. Am. J. Psychiatry, 143, 641-643.
5. Nerenz, D.R., Leventhal, H., Easterling, D.V., Love, R.R. (1986) Anxiety and drug taste as predictors of anticipatory nausea in cancer chemotherapy. J. Clin. Oncol., 4, 224-233.
6. Andrykowski, M.A. (1990) The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis. Psychosom. Med., 52, 458-475.
7. Greenberg, D.B., Surman, O.S., Clarke, J. (1987) Alprazolam for phobic nausea and vomiting related to cancer chemotherapy. Cancer Treat. Rep., 71, 549-550.
8. Holland, J.C., Morrow, G.R., Schmale, A. (1991) A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J. Clin. Oncol., 9, 1004-1011.
9. Razavi, D., Delvaux, N., Farvacques, C., De Brier, F., Van Heer, C., Kaufman, L. (1993) Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double blind, placebo-controlled study assessing the usefulness of alprazolam. J. Clin. Oncol., 11, 1384-1390.
10. Andrews, P.L.R., Davis, C.J. (1993) The mechanism of emesis induced by anti-cancer therapies. In Emesis in anti-cancer therapy. Mechanisms and treatment, edited by P.L.R. Andrews and G.J. Sanger, pp. 113-161. London. Chapman and Hall Medical.
11. 3 receptor antagonists the same ? Eur. J. Cancer, 28A (suppl. 1), S2-S6.
12. 3 antagonist. Eur. J. Cancer, 26 (Suppl. 1), S12-S15.
13. 3 antagonist ? Lancet, 340,1107-1108.
14. Lazlo, J., Clark, R.A., Hanson, D.C. (1985) Lorazepam in cancer patients treated with cisplatin: a drug with antiemetic, amnesic and anxiolytic effects. J. Clin. Oncol., 3, 864-869.
15. Tonato, M., Roila, F., Del Favero, A. (1991) Methodology of antiemetic trials: a review. Ann. Oncol., 2, 107-114.
16. Blijham, G.H. for the Granisetron study group. (1992) Does granisetron remain effective over multiple cycles ? Eur. J. Cancer, 28A (Suppl. 1), S17-S21.
17. Zook, D.J., Yasko, J.M. (1983) Psychologic factors: Their effect on nausea and vomiting experienced by clients receiving chemotherapy. Oncol. Nurs. Forum, 10, 76-81.
18. The Italian Group for Antiemetic Research. (1995) Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N. Engl. J. Med., 332, 1-5.